ストックスクリーナーアプリを入手
46.98
0.02%
-0.01
前日終値:
$46.99
開ける：
$46.98
24時間の取引高:
7.63M
Relative Volume:
1.48
時価総額：
$3.52B
収益：
-
当期純損益:
$-275.16M
株価収益率:
-12.08
EPS:
-3.89
ネットキャッシュフロー:
$-221.15M
1週間 パフォーマンス:
+0.04%
1か月 パフォーマンス:
+1.12%
6か月 パフォーマンス:
+29.24%
1年 パフォーマンス:
+25.18%
1日の値動き範囲:
$46.97
$47.00
1週間の範囲:
$46.93
$47.00
52週間の値動き範囲:
$28.21
$62.00
Springworks Therapeutics Inc Stock (SWTX) Company Profile
名前
Springworks Therapeutics Inc
セクター
電話
203-883-9490
住所
100 WASHINGTON BOULEVARD, STAMFORD, CT
SWTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
46.98 | 3.52B | 0 | -275.16M | -221.15M | -3.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-20 | 開始されました | Evercore ISI | Outperform |
| 2024-02-05 | 開始されました | Guggenheim | Buy |
| 2022-12-01 | 開始されました | BofA Securities | Buy |
| 2021-01-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-29 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-05 | 開始されました | Barclays | Overweight |
| 2020-03-19 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-04 | 開始されました | H.C. Wainwright | Buy |
| 2019-10-08 | 開始されました | Cowen | Outperform |
| 2019-10-08 | 開始されました | Goldman | Buy |
| 2019-10-08 | 開始されました | JP Morgan | Overweight |
| 2019-10-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Springworks Therapeutics Inc (SWTX) 最新ニュース
SpringWorks Therapeutics (NASDAQ:SWTX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Assenagon Asset Management S.A. Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
SpringWorks Therapeutics (SWTX) Continues Strong Yearly Run, Showing Over 29% YTD Gain - Daily Chhattisgarh News
Biotech Stocks To ConsiderJune 16th - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
FNY Investment Advisers LLC Purchases New Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics Announces Merger with Merck KGaA - TipRanks
SpringWorks Merger Moves Forward with Regulatory Clearances By Investing.com - Investing.com India
SpringWorks Merger Moves Forward with Regulatory Clearances - Investing.com
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OPOF, PRA, SWTX, FLS on Behalf of Shareholders - ACCESS Newswire
HAPPY FATHER’S DAY and $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger: OPOF, PRA, SWTX and FLS - ACCESS Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders - GlobeNewswire Inc.
SpringWorks Therapeutics’ SWOT analysis: stock outlook amid Merck acquisition - Investing.com
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
SpringWorks Therapeutics, Inc. Stock Update: Steady Performance Amid Market Trends - Daily Chhattisgarh News
Best Biotech Stocks To Research – June 9th - Defense World
Best Growth Stocks To Follow Now – June 9th - Defense World
Squarepoint Ops LLC Cuts Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
88,995 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Bought by RFG Advisory LLC - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Top Growth Stocks To Follow Now – June 4th - Defense World
Best Biotech Stocks Worth Watching – June 4th - Defense World
(SWTX) Proactive Strategies - news.stocktradersdaily.com
SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc.SWTX - Business Wire
Nuveen Asset Management LLC Has $6.64 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
$HAREHOLDER NOTICE: The M&A Class Action Firm Continues To Investigate The Merger - Benzinga
BNP Paribas Financial Markets Acquires Shares of 9,719 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Promising Growth Stocks To Research – May 28th - Defense World
ProShare Advisors LLC Acquires 5,503 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Deutsche Bank AG Purchases 19,540 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Merck, SpringWorks receive German antitrust approval for their deal - MLex
Palisades Investment Partners LLC Purchases 12,154 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Bank of America Corp DE Reduces Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (SWTX) Surged on Acquisition News - Insider Monkey
BNP Paribas Financial Markets Makes New $351,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Gets CHMP Nod for Mirdametinib in Rare Disease - Nasdaq
SpringWorks Gets CHMP Nod For Mirdametinib In Rare Disease - Barchart.com
142,300 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Bought by Zimmer Partners LP - MarketBeat
SpringWorks Therapeutics’ SWOT analysis: biotech stock faces acquisition challenges - Investing.com
Growth Stocks To Consider – May 23rd - Defense World
Growth Stocks To ConsiderMay 23rd - MarketBeat
(SWTX) Investment Analysis - news.stocktradersdaily.com
SpringWorks Therapeutics receives positive CHMP opinion for Mirdametinib for the treatment of adult and paediatric patients with NF1-PN | Health & Wellbeing | Lifestyle - The Phoenix Newspaper UK
Springworks Therapeutics Inc (SWTX) 財務データ
収益
当期純利益
現金流量
EPS
Springworks Therapeutics Inc (SWTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Islam Saqib | Chief Executive Officer |
Mar 03 '25 |
Sale |
54.24 |
49,000 |
2,657,656 |
954,869 |
| Islam Saqib | Chief Executive Officer |
Feb 20 '25 |
Sale |
60.30 |
29,328 |
1,768,401 |
1,034,625 |
| Ashar Bhavesh | Chief Commercial Officer |
Feb 20 '25 |
Sale |
61.19 |
1,016 |
62,168 |
62,053 |
| LYNCH DANIEL | Director |
Feb 20 '25 |
Sale |
60.22 |
47,600 |
2,866,534 |
82,944 |
1.11%
1.70%
大文字化:
|
ボリューム (24 時間):